Insider · CIK 0001242612

NEWTON ROGER S

Reports to the SEC for 2 companies · PLYMOUTH, MI

sec.gov

Transactions

Companies

Filings

CIK

0001242612

Forms 4 and 5

Insider transactions

36 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-03-12	ESPREsperion Therapeutics, Inc.S Sale	Director	SSale	−25K sh	$50.06	−$1.25M	548,726
2018-11-02	ESPREsperion Therapeutics, Inc.S Sale	Director	SSale	−227 sh	$50.76	−$11.5K	573,726
2018-11-01	ESPREsperion Therapeutics, Inc.S Sale	Director	SSale	−2,600 sh	$50.01	−$130K	573,953
2018-10-18	ESPREsperion Therapeutics, Inc.S Sale	Director	SSale	−100 sh	$50.00	−$5,000	576,553
2018-10-17	ESPREsperion Therapeutics, Inc.S Sale	Director	SSale	−12.7K sh	$50.02	−$634K	576,653
2018-10-16	ESPREsperion Therapeutics, Inc.S Sale	Director	SSale	−9,400 sh	$50.01	−$470K	589,326
2018-08-27	ESPREsperion Therapeutics, Inc.S Sale	Director	SSale	−700 sh	$53.68	−$37.6K	615,726
2018-08-27	ESPREsperion Therapeutics, Inc.S Sale	Director	SSale	−700 sh	$52.91	−$37K	615,026
2018-08-27	ESPREsperion Therapeutics, Inc.S Sale	Director	SSale	−4,200 sh	$51.46	−$216K	610,826
2018-08-27	ESPREsperion Therapeutics, Inc.S Sale	Director	SSale	−12.1K sh	$50.65	−$613K	598,726
2018-08-17	ESPREsperion Therapeutics, Inc.S Sale	Director	SSale	−7,300 sh	$50.06	−$365K	616,426
2018-05-23	ESPREsperion Therapeutics, Inc. · Stock Option (right tobuy)A Award	Director	AAward	+10.1K sh	—	—	10,100
2018-03-29	ESPREsperion Therapeutics, Inc.S Sale	Director	SSale	−9,044 sh	$73.26	−$663K	639,682
2018-03-29	ESPREsperion Therapeutics, Inc.S Sale	Director	SSale	+8,656 sh	$72.31	+$626K	631,026
2018-03-29	ESPREsperion Therapeutics, Inc.S Sale	Director	SSale	+7,100 sh	$71.36	+$507K	623,926
2018-03-29	ESPREsperion Therapeutics, Inc.S Sale	Director	SSale	+200 sh	$70.71	+$14.1K	623,726
2018-02-07	ESPREsperion Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+34.7K sh	$6.99	+$242K	652,334
2018-02-07	ESPREsperion Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−3,608 sh	$6.99	−$25.2K	648,726
2018-02-07	ESPREsperion Therapeutics, Inc. · Warrant to Purchase Common StockM Exercise/Conversion	Director	MExercise/Conversion	−34.7K sh	—	—	0
2017-12-12	ESPREsperion Therapeutics, Inc.G Gift	Director	GGift	−12K sh	—	—	617,683
2017-04-17	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	14,000
2015-03-18	ESPREsperion Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2015-01-02	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2013-12-20	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2013-07-23	ESPREsperion Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+90K sh	—	—	90,000
2013-07-01	ESPREsperion Therapeutics, Inc.C Conversion	Director	CConversion	+301K sh	—	—	587,337
2013-07-01	ESPREsperion Therapeutics, Inc.P Purchase	Director	PPurchase	+42.3K sh	$14.00	+$593K	629,683
2013-07-01	ESPREsperion Therapeutics, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−301K sh	—	—	0
2013-07-01	ESPREsperion Therapeutics, Inc. · Warrant to Purchase Preferred StockJ Other	Director	JOther	−242K sh	—	—	0
2013-07-01	ESPREsperion Therapeutics, Inc. · Warrant to Purchase Common StockJ Other	Director	JOther	+34.7K sh	—	—	34,651
2004-02-10	ESPERION THERAPEUTICS INC/MIStock Option (right to buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−544K sh	—	—	0
2004-02-05	ESPERION THERAPEUTICS INC/MIM Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+138K sh	—	—	503,677
2004-02-05	ESPERION THERAPEUTICS INC/MIU Disposition from Tender	Director, President & CEO	UDisposition from Tender	−504K sh	$35.00	−$17.6M	0
2004-02-05	ESPERION THERAPEUTICS INC/MIStock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−138K sh	—	—	543,807
2003-12-30	ESPERION THERAPEUTICS INC/MIG Gift	Director, President & CEO	GGift	−207K sh	—	—	366,047
2003-08-26	ESPERION THERAPEUTICS INC/MIS Sale	Director, President & CEO	SSale	−95K sh	$16.00	−$1.52M	572,293

Recent filings

Accepted (ET)
Mar 144
NEWTON ROGER S0001179110-19-003860
SEC(opens sec.gov)
Nov 24
NEWTON ROGER S0001179110-18-012494
SEC(opens sec.gov)
Oct 184
NEWTON ROGER S0001179110-18-012267
SEC(opens sec.gov)
Aug 294
NEWTON ROGER S0001179110-18-010995
SEC(opens sec.gov)
Aug 224
NEWTON ROGER S0001179110-18-010751
SEC(opens sec.gov)
May 254
NEWTON ROGER S0001179110-18-007557
SEC(opens sec.gov)
Mar 294
NEWTON ROGER S0001179110-18-004929
SEC(opens sec.gov)
Feb 94
NEWTON ROGER S0001179110-18-001910
SEC(opens sec.gov)

Companies

Address

C/O ESPERION THERAPEUTICS, INC. 46701 COMMERCE CENTER DRIVE

PLYMOUTH, MI, 48170